Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Perrigo Company PLC announces FDA final approval for store brand equivalent to Advil Congestion Relief Tablets, 200 mg/10 mg


Tuesday, 8 Jul 2014 08:48am EDT 

Perrigo Company PLC:Receives final approval from U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen and phenylephrine hydrochloride tablets, 200 mg/10 mg (over-the-counter), the store brand equivalent to Advil Congestion Relief Tablets, 200 mg/10 mg.Perrigo expects to begin shipments of product prior to upcoming cough/cold/flu season.Advil Congestion Relief Tablets, 200 mg/10 mg, (ibuprofen & phenylephrine hydrochloride tablets, 200 mg/10 mg) is indicated for the relief of sinus pressure, nasal swelling and congestion, and headache.Estimated annual sales of the product are about $18 mln. 

Company Quote

184.87
0.73 +0.40%
12:12pm EDT